Publications by authors named "Toru Sakura"

Claim this Profile
I
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.
Keiji Okinaka, Yukihiro Akeda, Yoshihiro Inamoto, Shigeo Fuji, Ayumu Ito, Toru Sakura

Clin Microbiol Infect· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Isamu Sugiura, Noriko Doki, Tomoko Hata, Ryuko Cho, Toshiro Ito, Toru Sakura

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
Shinichi Kako, Fumihiko Hayakawa, Kiyotoshi Imai, Junji Tanaka, Shuichi Mizuta, Toru Sakura

Int J Hematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival.
Hideki Nakasone, Shinichi Kako, Takayoshi Tachibana, Masatsugu Tanaka, Makoto Onizuka, Toru Sakura

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia.
Hideki Nakasone, Shinichi Kako, Takehiko Mori, Satoshi Takahashi, Makoto Onizuka, Toru Sakura

Bone Marrow Transplant· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
Hiroaki Shimizu, Akihiko Yokohama, Takuma Ishizaki, Nahoko Hatsumi, Satoru Takada, Toru Sakura

Leuk Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
Takeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, Tsutomu Takahashi, Maki Hagihara, Toru Sakura

Int J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
Hitoshi Minamiguchi, Hiroyuki Fujita, Yoshiko Atsuta, Norio Asou, Toru Sakura

Ann Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies.
Naoyuki Uchida, Kana Matsumoto, Toru Sakura, Michihiro Hidaka, Toshihiro Miyamoto

Int J Hematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes.
Nanami Gotoh, Yusuke Minato, Takayuki Saitoh, Noriyuki Takahashi, Tetsuhiro Kasamatsu, Toru Sakura

Eur J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature.
Akihiro Takeshita, Norio Asou, Yoshiko Atsuta, Hiroaki Furumaki, Toru Sakura

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.
Hitoshi Kiyoi, Joan D Morris, Iekuni Oh, Yoshinobu Maeda, Hironobu Minami, Toru Sakura

Cancer Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation.
Junya Kanda, Takakazu Kawase, Hidenori Tanaka, Hiroto Kojima, Yasuo Morishima, Toru Sakura

Biol Blood Marrow Transplant· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Toru Sakura

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant.
Hiroaki Shimizu, Noriko Doki, Heiwa Kanamori, Toru Sakura, Takehiko Mori

Bone Marrow Transplant· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.
Takeshi Takahashi, Kensuke Usuki, Kosei Matsue, Hitoshi Ohno, Toru Sakura, Sakura Sakajiri

Int J Hematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.
Fumihiko Kimura, Junya Kanda, Ken Ishiyama, Toshio Yabe, Kota Yoshifuji, Toru Sakura

Bone Marrow Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.
Masamitsu Yanada, Jinichi Mori, Jun Aoki, Masayoshi Masuko, Kaito Harada, Toru Sakura

Ann Hematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.
Yoshimitsu Shimomura, Masahiko Hara, Takayoshi Tachibana, Kazuteru Ohashi, Toru Sakura

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome.
Hidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, Jun Aoki, Takayuki Ishikawa, Toru Sakura

Ann Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).
Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, Hajime Kobayashi, Eisei Kondo, Toru Sakura

Int J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.
Takumi Hoshino, Satoru Takada, Nahoko Hatsumi, Toru Sakura

Int J Hematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation.
Ken Ishiyama, Jun Aoki, Hidehiro Itonaga, Naoyuki Uchida, Satoshi Takahashi, Toru Sakura

Blood Cancer J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.
Koichi Miyamura, Kazunori Ohnishi, Shigeki Ohtake, Noriko Usui, Chiaki Nakaseko, Toru Sakura

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Naomi Kawashima, Akimi Akashi, Yasunobu Nagata, Rika Kihara, Yuichi Ishikawa, Toru Sakura

Ann Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis